日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 Years

罗氟司特乳膏0.3%每日一次治疗2-11岁儿童轻度或中度斑块状银屑病的安全性、临床疗效和药代动力学早期证据

Hebert, Adelaide A; Guide, Shireen V; Groysman, Vlada; Gonzalez, Mercedes E; Blanco, Daisy; Laquer, Vivian; Seal, Melissa S; Thurston, Archie; Krupa, David; Snyder, Scott; Burnett, Patrick; Chu, David H; Berk, David R; Higham, Robert C

Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes

在全身性缺氧和高海拔地区人群中,人类肿瘤的趋同遗传适应

Carlota Arenillas ,Lucía Celada ,José Ruiz-Cantador ,Bruna Calsina ,Debayan Datta ,Eduardo García-Galea ,Roberta Fasani ,Ana Belén Moreno-Cárdenas ,Juan José Alba-Linares ,Berta Miranda-Barrio ,Ángel M Martínez-Montes ,Cristina Alvarez-Escola ,Beatriz Lecumberri ,Ana González García ,Shahida K Flores ,Emmanuel Esquivel ,Yanli Ding ,Mirko Peitzsch ,José-Ángel Robles-Guirado ,Rita Maria Regojo Zapata ,José Juan Pozo-Kreilinger ,Carmela Iglesias ,Trisha Dwight ,Christopher A Muir ,Amelia Oleaga ,Maria Elvira Garrido-Lestache Rodríguez-Monte ,Maria Jesús Del Cerro ,Isaac Martínez-Bendayán ,Enol Álvarez-González ,Tamara Cubiella ,Delmar Muniz Lourenço Jr ,Maria Adelaide A Pereira ,Nelly Burnichon ,Alexandre Buffet ,Craig Broberg ,Paxton V Dickson ,Mario F Fraga ,José Luis Llorente Pendás ,Joaquín Rueda Soriano ,Francisco Buendía Fuentes ,Sergio P A Toledo ,Roderick Clifton-Bligh ,Rodrigo Dienstmann ,Josep Villanueva ,Jaume Capdevila ,Anne-Paule Gimenez-Roqueplo ,Judith Favier ,Paolo Nuciforo ,William F Young Jr ,Nicole Bechmann ,Alexander R Opotowsky ,Anand Vaidya ,Irina Bancos ,Donate Weghorn ,Mercedes Robledo ,Anna Casteràs ,Laura Dos-Subirà ,Igor Adameyko ,María-Dolores Chiara ,Patricia L M Dahia ,Rodrigo A Toledo

Switching from Adalimumab Reference Product to and Among Adalimumab Biosimilars Outside the USA: Insights for US Clinicians

美国以外地区从阿达木单抗参考产品转换为阿达木单抗生物类似药以及在阿达木单抗生物类似药之间转换:对美国临床医生的启示

Tesser, John R P; Charabaty, Aline; Hebert, Adelaide A

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials

罗氟司特乳膏 0.3% 治疗慢性斑块状银屑病患者:DERMIS III 期试验的 PASI 和 PASI-HD 汇总结果

Papp, Kim A; Del Rosso, James Q; Lebwohl, Mark G; Gooderham, Melinda J; Hebert, Adelaide A; Hong, H Chih-Ho; Kircik, Leon H; Pariser, David M; Stein Gold, Linda; Strober, Bruce; Seal, Melissa S; Krupa, David; Chu, David H; Burnett, Patrick; Berk, David R; Higham, Robert C

Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

两项针对成人和儿童的3期特应性皮炎试验表明,他那洛夫可改善患者及其家人的预后和睡眠质量

Simpson, Eric L; Hebert, Adelaide A; Browning, John; Serrao, Rocco T; Sofen, Howard; Brown, Philip M; Piscitelli, Stephen C; Rubenstein, David S; Tallman, Anna M

Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease.

生殖系 VHL 变异的致病性与 von Hippel-Lindau 病中的肾细胞癌大小相关

Mori Gustavo H, Fagundes Gustavo F C, Santana Lucas S, Freitas-Castro Felipe, Afonso Ana Caroline F, Lourenço Delmar M Jr, Pereira Maria Adelaide A, Tanno Fabio Y, Srougi Victor, Chambo Jose L, Cordeiro Mauricio D, Nahas William C, Hoff Ana O, Fragoso Maria Candida B V, Mendonca Berenice B, Latronico Ana Claudia, Almeida Madson Q

Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial

每日一次使用0.05%罗氟司特乳膏治疗2-5岁轻中度特应性皮炎患儿的疗效和安全性(INTEGUMENT-PED):一项3期随机对照试验

Eichenfield, Lawrence F; Serrao, Rocco; Prajapati, Vimal H; Browning, John C; Swanson, Lisa; Funk, Tracy; Gonzalez, Mercedes E; Hebert, Adelaide A; Lee, Mark; Boguniewicz, Mark; Simpson, Eric L; Seal, Melissa S; Krupa, David; Hanna, Diane; Snyder, Scott; Burnett, Patrick; Chu, David H; Almaraz, Erin; Higham, Robert C; Berk, David R

MON-295 Histopathological Evaluation (HISTALDO) Predicts Outcome in Unilateral Primary Aldosteronism

MON-295 组织病理学评估 (HISTALDO) 可预测单侧原发性醛固酮增多症的预后

Pasqua, Analia V; Mazza, Oscar M; Goldbaum, Tatiana Silva; Ledesma, Felipe L; Guimaraes, Augusto G; Okubo, Jessica; Kawahara, Eduardo Z; Calsavara, Vinicius; Bortolloto, Luiz A; Chambo, Jose L; Villares Fragoso, Maria Candida Barisson; Pereira, Maria Adelaide A; Pio-Abreu, Andrea; Silva, Giovanio V; Silveira, Joao V; Consolim-Colombo, Fernanda; Drager, Luciano F; Nahas, William C; Latronico, Ana Claudia; Mendonca, Berenice B; Almeida, Madson Q; Zerbini, Maria Claudia N

Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients

执行摘要:甲氨蝶呤治疗儿童炎症性皮肤病的共识治疗指南

Brandling-Bennett, Heather A; Arkin, Lisa M; Chiu, Yvonne E; Hebert, Adelaide A; Callen, Jeffrey P; Castelo-Soccio, Leslie; Co, Dominic O; Cordoro, Kelly M; Curran, Megan L; Dalrymple, Austin M; Flohr, Carsten; Gordon, Ken B; Hanna, Diane; Irvine, Alan D; Kim, Susan; Kirkorian, A Yasmine; Lara-Corrales, Irene; Lindstrom, Jill; Paller, Amy S; Reyes, Melissa; Begolka, Wendy Smith; Tom, Wynnis L; Van Voorhees, Abby S; Vleugels, Ruth Ann; Lee, Lara Wine; Davies, Olivia; Siegfried, Elaine C

Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials

罗氟司特乳膏,0.15%,用于治疗成人和儿童特应性皮炎:INTEGUMENT-1 和 INTEGUMENT-2 随机临床试验

Simpson, Eric L; Eichenfield, Lawrence F; Alonso-Llamazares, Javier; Draelos, Zoe D; Ferris, Laura K; Forman, Seth B; Gooderham, Melinda; Gonzalez, Mercedes E; Hebert, Adelaide A; Kircik, Leon H; Lomaga, Mark; Moore, Angela; Papp, Kim A; Prajapati, Vimal H; Hanna, Diane; Snyder, Scott; Krupa, David; Burnett, Patrick; Almaraz, Erin; Higham, Robert C; Chu, David H; Berk, David R